Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Gliosarcoma 6Glioblastoma 6Central Nervous System Neoplasms 4Astrocytoma 4Brain Neoplasms 3Glioma 2Spinal Cord Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Filgrastim 10Ifosfamide 6Carboplatin 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Doxorubicin 4Cyclophosphamide 4pembrolizumab 3Thiotepa 3Temozolomide 3Etoposide 3Busulfan 3sargramostim 2ixabepilone 2fludarabine phosphate 2etoposide phosphate 2belinostat 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2Mycophenolic Acid 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Bortezomib 2Antilymphocyte Serum 2Amifostine 2tremelimumab 1seribantumab 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Lomustine × Sarcoma × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡